biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
10:31 Online advice: stop Ozempic-style drugs 1 to 3 months before pregnancy✦10:27 Eye vitamins did not slow late dry macular degeneration in clinic study✦10:27 Ozempic-style drug sped healing of diabetic foot sores in 105 older adults✦10:21 Inflammation pill showed gains in some early Parkinson's patients✦10:20 Pill added to prostate cancer radiation cut risk of spread or death by 58%✦04:19 Broccoli compound helped lab worms live over 50% longer, study finds✦04:16 A one-time gut procedure limited weight regain after Zepbound, maker says✦04:10 FDA drafts a quicker path to approval for some custom gene therapies✦10:31 Online advice: stop Ozempic-style drugs 1 to 3 months before pregnancy✦10:27 Eye vitamins did not slow late dry macular degeneration in clinic study✦10:27 Ozempic-style drug sped healing of diabetic foot sores in 105 older adults✦10:21 Inflammation pill showed gains in some early Parkinson's patients✦10:20 Pill added to prostate cancer radiation cut risk of spread or death by 58%✦04:19 Broccoli compound helped lab worms live over 50% longer, study finds✦04:16 A one-time gut procedure limited weight regain after Zepbound, maker says✦04:10 FDA drafts a quicker path to approval for some custom gene therapies
← All story threadsSTORY THREAD

Prostate cancer pill added to radiation for high-risk men.

1 report so far. New developments are added to this thread as they happen.

  1. Oct 28, 2026
    EARLY TRIAL LOOK: 58% LOWER RISK OF SPREAD OR DEATHControlled trial · 1,106 men

    Pill added to prostate cancer radiation cut risk of spread or death by 58%

    In a trial of 1,106 men with very high-risk prostate cancer, adding the pill darolutamide (Nubeqa) lowered the risk of spread or death. It is too early to say whether men live longer.